Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2021 Jun;27(6):1116.
doi: 10.1038/s41591-021-01363-0.

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J Ewer #  1 , Jordan R Barrett #  2 , Sandra Belij-Rammerstorfer #  2 , Hannah Sharpe  2 , Rebecca Makinson  2 , Richard Morter  2 , Amy Flaxman  2 , Daniel Wright  2 , Duncan Bellamy  2 , Mustapha Bittaye  2 , Christina Dold  3 , Nicholas M Provine  4 , Jeremy Aboagye  2 , Jamie Fowler  2 , Sarah E Silk  2 , Jennifer Alderson  5 , Parvinder K Aley  3 , Brian Angus  4 , Eleanor Berrie  6 , Sagida Bibi  3 , Paola Cicconi  3 , Elizabeth A Clutterbuck  3 , Irina Chelysheva  3 , Pedro M Folegatti  2 , Michelle Fuskova  2 , Catherine M Green  6 , Daniel Jenkin  2 , Simon Kerridge  3 , Alison Lawrie  2 , Angela M Minassian  2 , Maria Moore  3 , Yama Mujadidi  3 , Emma Plested  3 , Ian Poulton  2 , Maheshi N Ramasamy  3 , Hannah Robinson  3 , Rinn Song  3 , Matthew D Snape  3 , Richard Tarrant  6 , Merryn Voysey  3 , Marion E E Watson  2 , Alexander D Douglas  2 , Adrian V S Hill #  2 , Sarah C Gilbert #  2 , Andrew J Pollard #  3 , Teresa Lambe #  7 ; Oxford COVID Vaccine Trial Group
Collaborators, Affiliations
Published Erratum

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J Ewer et al. Nat Med. 2021 Jun.
No abstract available

PubMed Disclaimer

Erratum for

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
    Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, Flaxman A, Wright D, Bellamy D, Bittaye M, Dold C, Provine NM, Aboagye J, Fowler J, Silk SE, Alderson J, Aley PK, Angus B, Berrie E, Bibi S, Cicconi P, Clutterbuck EA, Chelysheva I, Folegatti PM, Fuskova M, Green CM, Jenkin D, Kerridge S, Lawrie A, Minassian AM, Moore M, Mujadidi Y, Plested E, Poulton I, Ramasamy MN, Robinson H, Song R, Snape MD, Tarrant R, Voysey M, Watson MEE, Douglas AD, Hill AVS, Gilbert SC, Pollard AJ, Lambe T; Oxford COVID Vaccine Trial Group. Ewer KJ, et al. Nat Med. 2021 Feb;27(2):270-278. doi: 10.1038/s41591-020-01194-5. Epub 2020 Dec 17. Nat Med. 2021. PMID: 33335323 Clinical Trial.

Publication types

LinkOut - more resources